Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management

Drug-induced thrombotic microangiopathy (DITMA) represents 10%–13% of all thrombotic microangiopathy (TMA) cases and about 20%–30% of secondary TMAs, just behind pregnancy-related and infection-related forms. Although the list of drugs potentially involved as causative for TMA are rapidly increasing...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Tommaso Mazzierli, Federica Allegretta, Enrico Maffini, Marco Allinovi
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-01-01
Serija:	Frontiers in Pharmacology
Teme:	thrombotic microangiopathy hemolytic-uremic syndrome thrombotic thrombocytopenic purpura drug-induced toxicity nephrotoxicity
Online dostop:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1088031/full
Oznake:	Označite Brez oznak, prvi označite!